The independent source for health policy research, polling, and news.
1,961-1,980 of 113,161 results
The closures come after months of financial struggle due to President Trump’s One Big Beautiful Bill blocking the organization from billing Medicaid. Planned Parenthood has brought the issue to the courts in a battle that is ongoing. Plus: the potential effects of antidepressants on teenage sexuality.
The plan allows a company or academic group to craft custom treatments for “several” patients and then apply for approval. Rather than the FDA approving an individual, unchangeable drug, it would allow those creators to keep crafting bespoke editors for new individuals with new mutations, Stat explains.
According to the Catholic Health Association, more than one in seven patients in the U.S. are treated at Catholic hospitals daily, with some communities having no alternative medical centers. Meanwhile, transgender service members are suing the Air Force after an announcement that it would deny them retirement benefits.
In a major shift in homelessness policy, the bulk of funding would be directed toward programs that prioritize work and drug treatment. Also: new patent policies' impact on lowering drug prices; pediatricians' reactions to the FDA's effort to limit fluoride supplements; and more.
The House voted Wednesday to fund the government through January, and President Donald Trump signed the measure that effectively ends the shutdown. Now, Democrats are maneuvering to force a vote on the expiring tax credits, while House Speaker Mike Johnson says he will not commit to bringing up the issue in his chamber, AP reports. Plus, what does this mean for SNAP benefits?
Today's early morning highlights from the major news organizations.
Individual countries are maintaining their standing, health officials say, but the U.S. might lose its elimination status if it can't get current outbreaks under control by January. Plus, two U.S. airports report measles exposures.
Editorial writers examine these public health issues.
A new report points to 27 completed or planned labor and delivery unit closures this year. Other industry news is on Genesis HealthCare, the fight between Blue Cross Blue Shield of Massachusetts and the UMass Memorial Health system, pediatric ER care, and more.
Pazdur will head the FDA's Center for Drug Evaluation and Research, replacing George Tidmarsh. Other pharma news is on telehealth prescriptions for certain controlled substances, health information privacy related to wearable devices and mobile health apps, and more.
The FDA issued the announcement Monday. Commissioner Marty Makary said the warnings were based on outdated science. Scroll down to our Editorials and Opinions section to read the story.
The Supreme Court's emergency ruling will expire by midnight Thursday, giving the House and President Trump just days to approve and sign a measure that would fund the government.
Republicans are floating ideas for discussion after the government reopens. One idea from Senate Majority Leader John Thune, R-S.D., would extend the soon-to-expire Obamacare subsidies in exchange for stricter abortion restrictions on insurance plans. Another idea from President Donald Trump would give federal health care funds directly to individuals instead of through insurers. Policy experts say Obamacare would collapse under that plan.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health topics.
The Task Force on Responsible Use of Natural Psychedelic Substances submitted its report on the benefits of easing restrictions on psilocybin, mescaline, and dimethyltryptamine, three natural psychedelics. Also in the news: Colorado, Ohio, Connecticut, North Carolina, Texas, California, and Louisiana.
Merck's new pill, enlicitide, and Amgen's longtime Repatha shot are showing heart attack risk-lowering potential, and researchers have made progress on the gene-editing front.
Researchers also found higher risks of chronic rhinitis, chronic rhinosinusitis, and nasal polyposis. Also, ByHeart baby formula has been recalled due to a multistate outbreak of infant botulism. Plus, research shows 1 in 27 women are informally sharing breast milk.
There's no specific plan for the payments, which Congress would likely need to approve. Meanwhile, the Supreme Court is hearing arguments about whether Trump overstepped his authority in levying tariffs without congressional support. Plus: Would 50-year mortgages help the housing crisis?
On Sunday night, an appeals court denied President Donald Trump's efforts to halt the release of full funding for November's payments. Trump also threatened Friday to penalize states that paid full benefits and ordered them to claw back the money. It's unclear if that demand still stands.
© 2026 KFF